| __timestamp | Arrowhead Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 5078000000 |
| Thursday, January 1, 2015 | 34718089 | 4717000000 |
| Friday, January 1, 2016 | 40998209 | 5096000000 |
| Sunday, January 1, 2017 | 32022880 | 4986000000 |
| Monday, January 1, 2018 | 19110051 | 4214000000 |
| Tuesday, January 1, 2019 | 26556257 | 3806000000 |
| Wednesday, January 1, 2020 | 52275890 | 3671000000 |
| Friday, January 1, 2021 | 80981000 | 3528000000 |
| Saturday, January 1, 2022 | 124431000 | 3445000000 |
| Sunday, January 1, 2023 | 90932000 | 3498000000 |
| Monday, January 1, 2024 | 98761000 | 3702000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Teva Pharmaceutical Industries Limited and Arrowhead Pharmaceuticals, Inc. over the past decade.
From 2014 to 2023, Teva's SG&A expenses have shown a downward trend, decreasing by approximately 31% from 2014 to 2023. In contrast, Arrowhead's expenses have surged by nearly 300% during the same period, reflecting its aggressive growth strategy. Notably, 2022 marked Arrowhead's peak, with expenses reaching 124 million, a significant leap from 19 million in 2014.
While Teva's 2024 data remains unavailable, Arrowhead's continued upward trajectory suggests a robust expansion plan. These trends highlight the contrasting strategies of these pharmaceutical giants, offering valuable insights for investors and industry analysts.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Teva Pharmaceutical Industries Limited
Vertex Pharmaceuticals Incorporated or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and CRISPR Therapeutics AG
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Novavax, Inc.
SG&A Efficiency Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.